Mylan Pharma UK Ltd.

Quick facts

Phase 3 pipeline

• Placebo inhalation solution QD
  Placebo has no active pharmacological mechanism and produces therapeutic effects solely through the placebo effect.

Phase 1 pipeline

• MGR001
• Revefenacin Inhalation Solution
• Seretide™ Accuhaler™

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Mylan Pharma UK Ltd. portfolio CI brief
• Mylan Pharma UK Ltd. pipeline updates RSS